Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Duffy

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMC Health Services Research|October 21, 2024
Supporting young people through the COVID-19 pandemic and beyond: a multi-site qualitative longitudinal studyMadelyn Whyte, Emily Nichol, Lisa D Hawke, et al.
Cancers|February 25, 2023
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with VerteporfinJiyong Liang, Dexing Fang, Joy Gumin, et al.
Annals of Case Reports|April 12, 2024
Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related DiseaseHinda Najem, Victor A Arrieta, Joseph Duffy, et al.
The Medical Journal of Australia|November 14, 2017
Integrated (one-stop shop) youth health care: best available evidence and future directionsSarah E Hetrick, Alan P Bailey, Kirsten E Smith, et al.
Archives of Neurology|September 14, 2011
Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein geneNeeraj Kumar, Bradley F Boeve, Brendon P Boot, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.
Neuro-Oncology|September 30, 2025
YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
MAPK/ERK signaling in gliomas modulates interferon responses, T cell recruitment, microglia phenotype, and immune checkpoint blockade efficacyKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Nature Communications|June 25, 2026
Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responsesKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2026
Microglial fructose metabolism is essential for glioblastoma growthLeah K Billingham, Susan L DeLay, Yasmina Eshac, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Health Services Research|October 21, 2024
Supporting young people through the COVID-19 pandemic and beyond: a multi-site qualitative longitudinal studyMadelyn Whyte, Emily Nichol, Lisa D Hawke, et al.
Cancers|February 25, 2023
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with VerteporfinJiyong Liang, Dexing Fang, Joy Gumin, et al.
Annals of Case Reports|April 12, 2024
Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related DiseaseHinda Najem, Victor A Arrieta, Joseph Duffy, et al.
The Medical Journal of Australia|November 14, 2017
Integrated (one-stop shop) youth health care: best available evidence and future directionsSarah E Hetrick, Alan P Bailey, Kirsten E Smith, et al.
Archives of Neurology|September 14, 2011
Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein geneNeeraj Kumar, Bradley F Boeve, Brendon P Boot, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.
Neuro-Oncology|September 30, 2025
YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
MAPK/ERK signaling in gliomas modulates interferon responses, T cell recruitment, microglia phenotype, and immune checkpoint blockade efficacyKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Nature Communications|June 25, 2026
Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responsesKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2026
Microglial fructose metabolism is essential for glioblastoma growthLeah K Billingham, Susan L DeLay, Yasmina Eshac, et al.
Pageof 2